Altimmune, Inc. — Director's Dealing 2010

Dec 29, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PHARMATHENE, INC (PIP)
CIK: 0001326190
Period of Report: 2010-12-23

Reporting Person: RICHMAN ERIC I (Director, See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-12-23	Common Stock, $0.0001 par value per share	A	35000	—	Acquired	112879	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-12-23	Stock Options (right to buy)	$3.91	A	225000	Acquired	2020-12-23	Common Stock (225000)	Direct

Footnotes

F1: This is a restricted stock award, which vests in full on the three month anniversary of the grant date.

F2: On December 23, 2010, the date such restricted shares and options were granted, the closing price of the Issuer's Common
Stock on the NYSE Amex was $3.91 per share.

F3: The options vest over a 4 year period with 25% each vesting on the first, second, third and fourth anniversaries of the grant
date.